Generics Makers Challenge AstraZeneca In Crestor MDL

Law360, New York (January 28, 2010, 3:54 PM EST) -- Teva Pharmaceuticals USA Inc., Apotex Corp. and a clutch of other generic-drug makers accused of infringing AstraZeneca PLC’s patent for the cholesterol drug Crestor are claiming the company's marketing unit lacks standing to partake in the multidistrict litigation.

On Wednesday the defendants urged Judge Joseph J. Farnan Jr. of the U.S. District Court for the District of Delaware to jettison AstraZeneca Pharmaceuticals LP, contending that unlike the other three plaintiffs, the entity merely markets the drug and has no proprietary rights in the patent-at-issue.

While the...
To view the full article, register now.